First Light Asset Management as of Dec. 31, 2017
Portfolio Holdings for First Light Asset Management
First Light Asset Management holds 52 positions in its portfolio as reported in the December 2017 quarterly 13F filing
| Company (Ticker) | Portfolio Weight | Valued At | Change in Shares | Share Count | Share Price |
|---|---|---|---|---|---|
| NeoGenomics (NEO) | 9.3 | $34M | 3.8M | 8.86 | |
| Nektar Therapeutics | 5.8 | $21M | 352k | 59.72 | |
| Array BioPharma | 5.5 | $20M | 1.6M | 12.80 | |
| AtriCure (ATRC) | 5.4 | $20M | 1.1M | 18.24 | |
| Entellus Medical Cm | 4.5 | $16M | 671k | 24.39 | |
| Omnicell (OMCL) | 4.2 | $15M | 317k | 48.50 | |
| Harvard Bioscience (HBIO) | 4.2 | $15M | 4.6M | 3.30 | |
| Ligand Pharmaceuticals In (LGND) | 4.2 | $15M | 112k | 136.93 | |
| Immunomedics | 4.2 | $15M | 944k | 16.16 | |
| Model N (MODN) | 4.1 | $15M | 944k | 15.75 | |
| Xencor (XNCR) | 3.9 | $14M | 645k | 21.92 | |
| Shire | 3.4 | $12M | 80k | 155.12 | |
| Nevro (NVRO) | 3.0 | $11M | 156k | 69.04 | |
| Cardiovascular Systems | 2.9 | $11M | 444k | 23.69 | |
| Halozyme Therapeutics (HALO) | 2.6 | $9.5M | 468k | 20.26 | |
| Oxford Immunotec Global | 2.3 | $8.3M | 597k | 13.97 | |
| Dynavax Technologies (DVAX) | 2.1 | $7.8M | 416k | 18.70 | |
| Heron Therapeutics (HRTX) | 2.0 | $7.5M | 414k | 18.10 | |
| Globus Med Inc cl a (GMED) | 2.0 | $7.3M | 177k | 41.10 | |
| Bluebird Bio | 1.9 | $6.7M | 38k | 178.10 | |
| Codexis (CDXS) | 1.8 | $6.7M | 804k | 8.35 | |
| Intersect Ent | 1.6 | $5.8M | 179k | 32.40 | |
| Teligent | 1.5 | $5.5M | 1.5M | 3.63 | |
| Quidel Corporation | 1.4 | $5.2M | 120k | 43.35 | |
| Veracyte (VCYT) | 1.4 | $5.2M | 791k | 6.53 | |
| Bio-techne Corporation (TECH) | 1.4 | $4.9M | 38k | 129.55 | |
| K2m Group Holdings | 1.3 | $4.9M | 271k | 18.00 | |
| HealthStream (HSTM) | 1.3 | $4.9M | 210k | 23.16 | |
| NxStage Medical | 1.3 | $4.7M | 193k | 24.23 | |
| LHC | 1.2 | $4.2M | 69k | 61.24 | |
| Vertex Pharmaceuticals Incorporated (VRTX) | 0.9 | $3.5M | 23k | 149.85 | |
| BioMarin Pharmaceutical (BMRN) | 0.8 | $2.8M | 31k | 89.16 | |
| IRIDEX Corporation (IRIX) | 0.7 | $2.4M | 318k | 7.62 | |
| Streamline Health Solutions | 0.6 | $2.3M | 1.4M | 1.69 | |
| iShares NASDAQ Biotechnology Index (IBB) | 0.6 | $2.3M | 21k | 106.76 | |
| Ionis Pharmaceuticals (IONS) | 0.6 | $2.1M | 42k | 50.30 | |
| Enzo Biochem (ENZB) | 0.5 | $1.9M | 237k | 8.15 | |
| Powershares Etf Tr Ii s^p smcp hc po | 0.5 | $1.7M | 17k | 98.52 | |
| Alkermes (ALKS) | 0.4 | $1.6M | 30k | 54.72 | |
| Health Care SPDR (XLV) | 0.4 | $1.5M | 18k | 82.67 | |
| LeMaitre Vascular (LMAT) | 0.4 | $1.5M | 46k | 31.83 | |
| Celgene Corporation | 0.4 | $1.4M | 14k | 104.35 | |
| Macrogenics (MGNX) | 0.4 | $1.4M | 74k | 19.01 | |
| iShares Dow Jones US Medical Dev. (IHI) | 0.4 | $1.3M | 7.6k | 173.48 | |
| SPDR S&P Biotech (XBI) | 0.2 | $806k | 9.5k | 84.85 | |
| Abbvie (ABBV) | 0.1 | $402k | 4.2k | 96.66 | |
| Pfizer (PFE) | 0.1 | $310k | 8.6k | 36.22 | |
| Johnson & Johnson (JNJ) | 0.1 | $305k | 2.2k | 139.72 | |
| Novartis (NVS) | 0.1 | $300k | 3.6k | 83.99 | |
| Sanofi-Aventis SA (SNY) | 0.1 | $289k | 6.7k | 43.01 | |
| Dynatronics | 0.1 | $301k | 104k | 2.88 | |
| Merck & Co (MRK) | 0.1 | $242k | 4.3k | 56.36 |
